Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127230581 | 12723058 | 1 | I | 20160427 | 20160907 | 20160908 | 20160908 | EXP | CN-ROCHE-1827006 | ROCHE | 58.26 | YR | F | Y | 48.00000 | KG | 20160908 | OT | CN | CN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127230581 | 12723058 | 1 | PS | AVASTIN | BEVACIZUMAB | 1 | Intraperitoneal | U | H0144802 | 125085 | 300 | MG | QD | ||||||
| 127230581 | 12723058 | 2 | SS | GEMCITABINE HYDROCHLORIDE. | GEMCITABINE HYDROCHLORIDE | 1 | Intravenous drip | U | C237956D | 0 | 1.4 | G | POWDER FOR INJECTION | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127230581 | 12723058 | 1 | Pancreatic carcinoma |
| 127230581 | 12723058 | 2 | Pancreatic carcinoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127230581 | 12723058 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127230581 | 12723058 | Anaemia | |
| 127230581 | 12723058 | Bone marrow failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127230581 | 12723058 | 1 | 20160419 | 20160419 | 0 | |
| 127230581 | 12723058 | 2 | 20160419 | 20160419 | 0 |